Literature DB >> 16882296

Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.

E Chryssanthou1, M Cuenca-Estrella.   

Abstract

The susceptibilities of 40 clinical isolates of Aspergillus spp. (Aspergillus fumigatus, Aspergillus flavus, Aspergillus niger, Aspergillus terreus) were determined for posaconazole and voriconazole by the CLSI M38-A and EUCAST-AFST broth dilution methods. Where a discrepancy was observed between the methods, the EUCAST method tended to give higher MIC values. Overall, the level of agreement was 92.5% and the intra-class correlation coefficient was > 0.90.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882296     DOI: 10.1111/j.1469-0691.2006.01419.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  14 in total

1.  The composition of the culture medium influences the β-1,3-glucan metabolism of Aspergillus fumigatus and the antifungal activity of inhibitors of β-1,3-glucan synthesis.

Authors:  Cécile Clavaud; Anne Beauvais; Lise Barbin; Hélène Munier-Lehmann; Jean-Paul Latgé
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

2.  Comparison of the broth microdilution methods of the European Committee on Antimicrobial Susceptibility Testing and the Clinical and Laboratory Standards Institute for testing itraconazole, posaconazole, and voriconazole against Aspergillus isolates.

Authors:  M Pfaller; L Boyken; R Hollis; J Kroeger; S Messer; S Tendolkar; D Diekema
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

3.  Genetic Diversity and In Vitro Antifungal Susceptibility of 200 Clinical and Environmental Aspergillus flavus Isolates.

Authors:  Mojtaba Taghizadeh-Armaki; Mohammad Taghi Hedayati; Saham Ansari; Saeed Mahdavi Omran; Sasan Saber; Haleh Rafati; Jan Zoll; Henrich A van der Lee; Willem J G Melchers; Paul E Verweij; Seyedmojtaba Seyedmousavi
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.

Authors:  Cornelia Lass-Flörl; Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Susanne Perkhofer; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2008-12-08       Impact factor: 5.191

5.  In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?

Authors:  Susanne Perkhofer; Cornelia Mrazek; Lukas Hartl; Cornelia Lass-Flörl
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 6.  The molecular mechanism of azole resistance in Aspergillus fumigatus: from bedside to bench and back.

Authors:  Xiaolei Wei; Yuanwei Zhang; Ling Lu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

Review 7.  Antifungal pharmacokinetics and pharmacodynamics.

Authors:  Alexander J Lepak; David R Andes
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

8.  Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Authors:  A Espinel-Ingroff; M Cuenca-Estrella; A Fothergill; J Fuller; M Ghannoum; E Johnson; T Pelaez; M A Pfaller; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2011-08-29       Impact factor: 5.191

9.  A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.

Authors:  K L Mortensen; H K Johansen; K Fuursted; J D Knudsen; B Gahrn-Hansen; R H Jensen; S J Howard; M C Arendrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-04       Impact factor: 3.267

10.  Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.

Authors:  Ricardo Araujo; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.